Latest Intellectual Property News

Recce Pharmaceuticals has locked in a non-dilutive A$30 million debt facility with Avenue Capital Group, extending its cash runway to support pivotal Phase 3 trials and commercialisation of its synthetic anti-infective R327G.

Impact Minerals Limited has released a robust Preliminary Feasibility Study for its Lake Hope High Purity Alumina project, revealing strong economics and a maiden Ore Reserve. The company is advancing towards a Definitive Feasibility Study and pilot plant construction, positioning itself for low-cost, low-carbon HPA production.

HeraMED has partnered with RMIT University and the Digital Health CRC to develop AI-driven maternity care models focused on culturally diverse populations, aiming to improve pre-term delivery risk prediction and personalised care.

Adisyn Ltd has successfully completed a key R&D program on low-temperature graphene deposition, earning full approval and final payment of a $520,000 grant from the Israel Innovation Authority. This milestone validates its cutting-edge semiconductor technology aimed at revolutionizing AI and high-performance computing.

Globe Metals & Mining announces the resignation of CEO Paul Smith and appoints CFO Charles Altshuler as Interim CEO, who will retain his CFO duties while steering the company forward.

Mesoblast reports positive FDA progress on accelerated approval for Revascor in ischemic heart failure and plans a pivotal trial to extend Ryoncil’s label to adults with graft versus host disease, while its US commercial launch outpaces expectations.

dorsaVi has secured exclusive worldwide rights to cutting-edge RRAM technology from NTU Singapore, promising to revolutionize its wearable sensor products with enhanced performance and energy efficiency. This strategic move positions the company for expansion into healthcare, elite sports, and industrial IoT markets.

EVE Health Group has launched a $1.5 million capital raise alongside the acquisition of biotech firm Nextract, aiming to expand its footprint in health and pharmaceutical products focused on erectile dysfunction and period pain.

FOS Capital is set to acquire Aldridge Traffic Systems' street lighting assets for $3.1 million, backed by a $3.7 million equity raise to fund the deal and expansion plans.

FOS Capital has secured $3.7 million through a placement to fund its acquisition of Aldridge Traffic Systems, aiming to expand its footprint in the Australian lighting market. The deal includes key assets and intellectual property, positioning FOS for accelerated growth.

IperionX has secured its first U.S. Army task order worth $1.3 million under a $99 million SBIR Phase III contract, marking a significant step in reshoring titanium production for U.S. defense needs.

Cyclopharm Limited has secured the maximum five-year U.S. patent extension for its flagship Technegas® Kit, extending market exclusivity to 2031 and reinforcing its strategic foothold in pulmonary imaging.